Add time:07/23/2019         Source:sciencedirect.com

In an effort to develop a new type of HCV NS3 peptidomimetic inhibitor, a series of tripeptide inhibitors incorporating a mix of α- and β-amino acids has been synthesized. To understand the structural implications of β-amino acid substitution, the P1, P2, and P3 positions of a potent tripeptide scaffold were scanned and combined with carboxylic acid and acyl sulfonamide C-terminal groups. Inhibition was evaluated and revealed that the structural changes resulted in a loss in potency compared with the α-peptide analogues. However, several compounds exhibited μM potency. Inhibition data were compared with modeled ligand–protein binding poses to understand how changes in ligand structure affected inhibition potency. The P3 position seemed to be the least sensitive position for β-amino acid substitution. Moreover, the importance of a proper oxyanion hole interaction for good potency was suggested by both inhibition data and molecular modeling. To gain further insight into the structural requirements for potent inhibitors, a three-dimensional quantitative structure–activity relationship (3D-QSAR) model has been constructed using comparative molecular field analysis (CoMFA). The most predictive CoMFA model has q2 = 0.48 and rpred2=0.68.

We also recommend Trading Suppliers and Manufacturers of Cyclopropanecarboxylic acid, 1-[[(1-aminocyclopropyl)carbonyl]amino]-, methyl (cas 123519-22-2). Pls Click Website Link as below: cas 123519-22-2 suppliers